You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 466 Combined inhibition of KRAS G12C and PD-1 boosts the therapeutic efficacy via conditioning of tumor microenvironment in pre-clinical humanized NSCLC mouse models

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
466 Combined inhibition of KRAS G12C and PD-1 boosts the therapeutic efficacy via conditioning of tumor microenvironment in pre-clinical humanized NSCLC mouse models

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023152013
Dec 20235506
Jan 20242202
Feb 20244002
Mar 20244404
Apr 20245805
May 20243602
Jun 202449011
Jul 20242806
Aug 20247209
Sep 202462010
Oct 20246609
Nov 20247206
Dec 202482010
Jan 2025100012
Feb 20251408
Mar 20250011
Apr 2025109
May 2025005
Jun 2025006
Total9530146